Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Guardian Pharmacy Services , Inc. (NYSE:GRDN), a $1.34 billion market cap pharmacy services provider whose stock has gained over 32% in the past six months, has announced the approval of long-term incentive awards for two of its executive officers, as per a recent SEC filing dated February 5, 2025. According to InvestingPro data, the company currently trades at $19.85 per share. The company’s 2025 long-term incentive program (LTIP), which falls under Guardian’s 2024 Equity and Incentive Compensation Plan, includes the issuance of restricted stock unit awards (RSUs) valued at $240,000 each to David Morris, Executive Vice President and Chief Financial Officer, and Kendall Forbes, Executive Vice President of Sales & Operations. These RSUs are set to vest in full on February 5, 2028.
In addition to the equity awards, Guardian Pharmacy’s Compensation Committee has also approved payouts for its 2024 annual cash incentive awards. Based on the achievement of target performance metrics, including company revenue, adjusted EBITDA, and residents served, the executive officers are entitled to cash awards amounting to 60% of their 2024 base salary. Consequently, the Committee has sanctioned payouts at 100% of the target for each executive officer. Fred Burke, the President and CEO, received $270,000, while Morris and Forbes each received $240,000.
Fred Burke, who holds a significant ownership stake in Guardian Pharmacy, abstained from receiving additional equity awards to allow for a more extensive distribution of equity among company executives.
This information is based on a press release statement and reflects the latest financial incentives provided to Guardian Pharmacy’s executive team as part of their compensation package. The company, headquartered in Atlanta, Georgia, operates within the retail drug stores and proprietary stores industry and is recognized under SIC code 5912. With revenue growth of nearly 17% in the last twelve months and a moderate debt level, Guardian maintains a FAIR overall financial health score according to InvestingPro analysis, which offers 6 additional key insights about the company’s performance and outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.